Form 4: Justin Dye Reports Acquisition of Medicine Man Technologies Shares as Director

Justin Dye, a director and 10% owner of Medicine Man Technologies, acquired 192,308 shares of common stock on June 28, 2024, as compensation for board service.

Summary

• Justin Dye, a director and 10% owner of Medicine Man Technologies, reported changes in beneficial ownership of the company's stock.
• On June 28, 2024, Dye acquired 192,308 shares of common stock as compensation for his service on the board of directors, valued at $75,000.
• Following the transaction, Dye directly owns 2,023,287 shares.
• Dye also indirectly owns 9,287,500 shares through Dye Capital & Company and 500,000 shares through Dye Capital LLLP, but disclaims beneficial ownership except to the extent of his pecuniary interest.
• The report was filed on July 2, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions. The director's acquisition could be seen as a positive, but it's relatively small.

Positives

• The acquisition of shares by a director could be seen as a positive sign of confidence in the company's future.

Industry Context

This filing is a routine disclosure required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's stock.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

beneficial ownership, Medicine Man Technologies, Justin Dye, director, SHWZ, stock acquisition, Form 4, Dye Capital, Dye Capital LLLP